Recent news on

'Chalex'ellence at Relay for Life  -  Apr 25, 2007
Middlebury Campus (subscription),It's 3 am on Saturday morning and the hundreds of walkers who swarmed the soccer field Friday afternoon to participate in Middlebury's annual cancer

'Chalex'ellence at Relay for Life  -  Apr 25, 2007
Middlebury Campus (subscription),It's 3 am on Saturday morning and the hundreds of walkers who swarmed the soccer field Friday afternoon to participate in Middlebury's annual cancer

Easter 'eggs-ellence' at the Vale Resort  -  Mar 13, 2007
Easier,The hunt for the perfect Easter break is now over thanks to a ‘cracking’ deal from the Vale Hotel, Golf and Spa Resort, that will allow each member of the

Drug firms' funding of advocates often escapes government scrutiny  -  Mar 18, 2007
Boston Globe,...treatment must figure into the treatment decision," Brown said in a press release touting Ellence , a breast cancer drug that showed lower heart risk.

Young sprinter's on the fast track  -  Feb 15, 2007
Nassau Guardian,Running for the Spirit of Exc-ellence Track Club, Butler pulled off a sprint double this past weekend by also winning the 200 m, and had previously done the

Re-Induction Chemotherapy May Improve Survival for Some Patients ...  -  Jan 2, 2007
Cancer Consultants (press release),Those who did not achieve pCR were either treated with additional adjuvant chemotherapy (Ellence 100 mg/m2 q 21 days x 3 followed by Taxotere® (docetaxel)

New Data On Pfizer's Aromasin and Ellence to Be Presented at San ...  -  Dec 14, 2006
PR Newswire (press release),..."New data are showing that Aromasin and Ellence can improve the outcomes for women with breast cancer," said Dr. Charles Baum, vice president of Pfizer

Pfizer reports positive trials from Aromasin, Ellence drugs  -  Dec 14, 2006
Forbes,NEW YORK (AFX) - Pfizer Inc reported positive trials from its Aromasin and Ellence drugs, which are used in the treatment of breast cancer.

Pfizer (PFE) Says Positive Data On Aromasin and Ellence Will Be ...  -  Dec 14, 2006
StreetInsider.com (subscription),Results of two studies evaluating the hormonal therapy Aromasin and the chemotherapy Ellence will be presented at the San Antonio Breast Cancer Symposium

Low Hematologic Toxicity Rate for Gemzar® and Ellence® in Advanced ...  -  Nov 28, 2006
Cancer Consultants (press release),Researchers from Italy have reported that the combination of Gemzar (gemcitabine) and Ellence (oxaliplatin) (GEMOX) has a good toxicity profile and

Additional Chemotherapy May Improve Survival for Some Patients ...  -  Dec 18, 2006
Cancer Consultants (press release),This trial included 48 patients who were all initially treated with the chemotherapy drugs Platinol® (cisplatin), Ellence® (epirubicin), and Navelbine®

Market Report -- In Play (PFE)  -  Dec 14, 2006
MSN MoneyPfizer announces "New data are showing that Aromasin and Ellence can improve the outcomes for women with breast cancer " Co announces results of two studies

Ten-year Survival of Patients with Localized Inflammatory Breast ...  -  Nov 27, 2006
Cancer Consultants (press release),Researchers from France recently reported results from a trial that evaluated high-dose 5-FU/Ellence/Cytoxan (FEC-HD) in the treatment of 120 women with

Sección internacional  -  Dec 14, 2006
Bolsamania.com,...(PRN) - New Data On Pfizer's Aromasin and Ellence to Be Presented at San Antonio Breast Cancer Symposium ... [+]. (PRN) - Tavant Technologies Appoints

Teva and Pfizer Make Up  -  Nov 27, 2006
Motley FoolThat drug, named Ellence, has produced sales of $68 million in the first half of this year for Pfizer. The option to market Ellence isn't such a great coup

Ellence® and CMF Superior to CMF Alone for Adjuvant Therapy of ...  Nov 2, 2006
British researchers associated with the National Epirubicin Adjuvant Trial (NEAT) have reported that Ellence (epirubicin) plus CMF (cyclphosphamide ... -Cancer Consultants (press release), 'Super Cocktail' Could Be Breakthrough In Breast Cancer  Nov 3, 2006
The cocktail adds a fourth drug, called epirubicin, and it's sold under the brand name Ellence. The study appears in the New England Journal of Medicine. -NBC5.com, Intensive Neoadjuvant Therapy Benefits ER Negative and/or HER-2 ...  Oct 31, 2006
Researchers from Italy have reported that weekly Platinol® (cisplatin), Ellence® (epirubicin), Taxol® (paclitaxel) with Neupogen® (filgrastim) support ... -Cancer Consultants (press release), 10-Year Survival of Patients With Localized Inflammatory Breast ...  Nov 1, 2006
...in 120 patients with non-metastatic inflammatory breast cancer treated with a high-dose chemotherapy regimen of fluorouracil (5-FU), Ellence® (epirubicin) and ... -Cancer Consultants (press release), Pfizer to Transform In Rapidly Changing Healthcare Environment  Oct 19, 2006
224 200 12 DETROL/ DETROL LA 295 231 28 207 160 29 88 71 25 - ONCOLOGY 540 507 7 224 193 16 316 314 1 CAMPTOSAR 218 229 (5) 122 119 2 96 110 (12) ELLENCE 77 86 ... -Yahoo! News (press release) Mayne Pharma receives FDA approval for cancer drug  Sep 20, 2006
...administered by injection. Epirubicin, sold under the brand name Ellence, generated sales of approximately $68 million in the US market. -Pharmaceutical Business Review

Mayne requests trading halt on shares  Sep 18, 2006
Sales of epirubicin the US under Pfizer Inc's Ellence brand - the exclusive marketing rights expired this month - generated about $US68 million per annum ... -The Age

Pfizer Unit Drops Bid to Block Mayne's Cancer Drug (Update1)  Sep 14, 2006
...from selling a cheaper version of Ellence, a treatment for early stage breast cancer. ... Ellence has been on the US market since 1999. ... -Bloomberg

Australia's Mayne Pharma receives US approval for epirubicin drug  Sep 18, 2006
...company. Epirubicin, sold under the brand name Ellence, generated sales of about 68 mln usd in the US market in the year to June. ... -Forbes

World News | Mayne Pharma heading for $1.5bn takeover? - 20/09 ...  Sep 20, 2006
Yesterday the company said it had own approval in the USA for its breast cancer drug epirubicin, a generic version of Pfizer's Ellence which will address a ... -Pharma Times (subscription)

Chargers-Raiders matchups  Sep 11, 2006
...faiders 3". strive for exc ellence wrote on September 11, 2006 1:12 PM:"usanaman... are you speaking of the same Charger team.. a ... -North County Times

Business Topics by Industry  Sep 13, 2006
Pfizer Inc., the world's biggest drug maker, sued Mayne Pharma Ltd. to block sales of a cheaper version of Ellence, a treatment for early-stage breast cancer. -Sun-Sentinel.com

Low Hematologic Toxicity Rate for Gemzar® and Ellence® in Advanced ...  -  Nov 28, 2006
Cancer Consultants (press release),Researchers from Italy have reported that the combination of Gemzar (gemcitabine) and Ellence (oxaliplatin) (GEMOX) has a good toxicity profile and

Further Evidence for Activity of Gemzar® and Ellence® in Advanced ...  -  Nov 21, 2006
Cancer Consultants (press release),...with a regimen of Gemzar (gemcitabine) and Ellence (oxaliplatin) (GEMOX). The details of this study appeared in the December 2006 issue of Lung Cancer.

Ten-year Survival of Patients with Localized Inflammatory Breast ...  -  Nov 27, 2006
Cancer Consultants (press release),Researchers from France recently reported results from a trial that evaluated high-dose 5-FU/Ellence/Cytoxan (FEC-HD) in the treatment of 120 women with

Teva and Pfizer Make Up  -  Nov 27, 2006
Motley FoolThat drug, named Ellence, has produced sales of $68 million in the first half of this year for Pfizer. The option to market Ellence isn't such a great coup

UPDATE 1-Pfizer, Teva settle patent fight over two drugs  -  Nov 21, 2006
ReutersThe deal also includes an option in 2007 for Teva to sell its own generic version of another cancer drug, Ellence, prior to the August 2007 patent expiry,

Teva, Pfizer settle 2 lawsuits  -  Nov 21, 2006
Ynetnews,The agreement also gives Teva the option to sell a generic version of Pfizer's Ellence cancer drug in 2007 before the patent expires in August.

Teva, Pfizer Reach Patent Deal  -  Nov 21, 2006
TheStreet.comTeva also has an option in 2007 to sell generic epirubicin, a chemotherapy sold by Pfizer as Ellence, prior to the patent expiration next August.

Pfizer settles patent suits against Teva  -  Nov 21, 2006
Crain's New York Business,Teva will also be able to sell a generic version of epirubucin, a cancer medicine sold by Pfizer under the name Ellence, prior to its patent expiration in

Early Look At The Market – UTR morning view  Aug 21, 2006
...(Bloomberg) Mayne Pharma FDA grants tentative approval for epirubicin HCL injection (PFE's Ellence). OXGN COO Steve Young leaves to pursue other interests. ... -E-Wire

Maintenance Taxol® Does Not Improve Outcomes in Metastatic Breast ...  Aug 23, 2006
...breast cancer. The trial included 215 patients who were initially treated with Ellence® or Adriamycin® plus Taxol. All patients ... -Cancer Consultants

Sewage ponds to be decommissioned  Aug 14, 2006
The technical officer for sewerage in the Serowe/Palapye Sub-District Ellence Kavezere told BOPA that the council was awaiting for guidance from the contractor ... -Republic of Botswana

High-dose Dense Chemotherapy and Radiation Therapy for Women with ...  Jul 21, 2006
The clinical trial reported by Italian researchers involved the administration of a mobilizing course of chemotherapy with Ellence® (epirubicin), Taxol ... -Cancer Consultants

Pfizer Delivers Strong Second-Quarter 2006 Results, Driven By ...  Jul 20, 2006
217 (1) DETROL/ DETROL LA 255 222 15 176 142 24 79 80 (2) - ONCOLOGY 540 513 5 211 178 19 329 335 (2) CAMPTOSAR 238 233 2 130 123 6 108 110 (1) ELLENCE 86 96 ... -PR Newswire

ECF Chemotherapy Prior to and Following Surgery Improves Survival ...  Jul 10, 2006
...to results recently published in the New England Journal of Medicine, treatment with the chemotherapy combination referred to as ECF (Ellence®, Platinol®, 5 ... -Cancer Consultants

Pre- and Post-Operative Chemotherapy Improves Overall Survival in ...  Jul 7, 2006
...cancer; 250 of whom were in the chemotherapy arm, which included three cycles of pre- and postoperative of bolus Ellence® (epirubicin), infusional Platinol ... -Cancer Consultants



Pfizer First-Quarter 2006 Financial Results Reflect Operating and ...  Apr 19, 2006
193 208 (7) DETROL/ DETROL LA 260 252 3 185 180 3 75 72 4 - ONCOLOGY 470 479 (2) 179 164 10 291 315 (8) CAMPTOSAR 212 212 - 112 104 8 100 108 (8) ELLENCE 73 90 ... - International News Service



Genta Appoints Seasoned Pharma Executive, Lloyd Sanders, as Vice ...  Jan 17, 2006
2000, led a 90-member sales force, and shared responsibility for the sales success of products that included Camptosar(R) (irinotecan), Ellence(R) (epirubicin ... - PR Newswire

Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect ...  Jan 19, 2006
221 (1) DETROL/ DETROL LA 283 285 (1) 193 207 (7) 90 78 15 - ONCOLOGY 497 453 10 167 182 (8) 330 271 22 CAMPTOSAR 237 189 25 124 123 1 113 66 69 ELLENCE 94 90 ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional